The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1311-1318.e7, December 2009

ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia

  • Christie-Ann McCarl, BS

      Affiliations

    • Department of Pathology, New York University, Langone Medical Center, New York, NY
    • Department of Pathology, Harvard Medical School, Program in Cellular and Molecular Medicine, Children's Hospital Boston, and Immune Disease Institute, Boston, Mass
    • These authors contributed equally to this work.
  • ,
  • Capucine Picard, MD, PhD

      Affiliations

    • Study Center of Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Paris, France
    • Human Genetics of Infectious Disease INSERM U550, Necker Faculty, Paris, France
    • Paris Descartes University, Paris, France
    • These authors contributed equally to this work.
  • ,
  • Sara Khalil, BS

      Affiliations

    • Department of Pathology, New York University, Langone Medical Center, New York, NY
    • These authors contributed equally to this work.
  • ,
  • Takumi Kawasaki, PhD

      Affiliations

    • Department of Pathology, New York University, Langone Medical Center, New York, NY
  • ,
  • Jens Röther

      Affiliations

    • Department of Pathology, Harvard Medical School, Program in Cellular and Molecular Medicine, Children's Hospital Boston, and Immune Disease Institute, Boston, Mass
  • ,
  • Alexander Papolos, BS

      Affiliations

    • Department of Pathology, New York University, Langone Medical Center, New York, NY
  • ,
  • Jeffery Kutok, MD

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital, Boston, Mass
  • ,
  • Claire Hivroz, PhD

      Affiliations

    • INSERM U768, Necker-Enfants Malades Hospital, Paris, France
    • INSERM U653 Curie Institut, Paris, France
  • ,
  • Francoise LeDeist, MD, PhD

      Affiliations

    • Study Center of Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Paris, France
    • INSERM U768, Necker-Enfants Malades Hospital, Paris, France
    • Département de Microbiologie et d'Immunologie et centre de recherche, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada
  • ,
  • Katrin Plogmann, DMD

      Affiliations

    • Department of Operative Dentistry and Periodontology, University of Freiburg, Freiburg, Germany
  • ,
  • Stephan Ehl, MD

      Affiliations

    • Center of Chronic Immunodeficiency, University of Freiburg, Freiburg, Germany
  • ,
  • Gundula Notheis, MD

      Affiliations

    • Department of Infection and Immunity, Dr von Haunersches Kinderspital, Ludwig-Maximilians-Universität, Munich, Germany
  • ,
  • Michael H. Albert, MD

      Affiliations

    • Department of Pediatric Hematology/Oncology, Dr von Haunersches Kinderspital, Ludwig-Maximilians-Universität, Munich, Germany
  • ,
  • Bernd H. Belohradsky, MD

      Affiliations

    • Department of Infection and Immunity, Dr von Haunersches Kinderspital, Ludwig-Maximilians-Universität, Munich, Germany
  • ,
  • Janbernd Kirschner, MD

      Affiliations

    • Department of Neuropediatrics and Muscle Disorders, University of Freiburg, Freiburg, Germany
  • ,
  • Anjana Rao, PhD

      Affiliations

    • Department of Pathology, Harvard Medical School, Program in Cellular and Molecular Medicine, Children's Hospital Boston, and Immune Disease Institute, Boston, Mass
    • These authors contributed equally to this work.
  • ,
  • Alain Fischer, MD

      Affiliations

    • INSERM U768, Necker-Enfants Malades Hospital, Paris, France
    • Pediatric Hematology-Immunology Unit, Necker-Enfants Malades Hospital, Paris, France
    • Paris Descartes University, Paris, France
    • These authors contributed equally to this work.
  • ,
  • Stefan Feske, MD

      Affiliations

    • Department of Pathology, New York University, Langone Medical Center, New York, NY
    • Department of Pathology, Harvard Medical School, Program in Cellular and Molecular Medicine, Children's Hospital Boston, and Immune Disease Institute, Boston, Mass
    • Corresponding Author InformationReprint requests: Stefan Feske, MD, Department of Pathology, New York University Langone Medical Center, 550 First Avenue, New York, NY 10016.

Received 17 August 2009; received in revised form 8 October 2009; accepted 9 October 2009.

Background

Defects in the development or activation of T cells result in immunodeficiency associated with severe infections early in life. T-cell activation requires Ca2+ influx through Ca2+-release activated Ca2+ (CRAC) channels encoded by the gene ORAI1.

Objective

Investigation of the genetic causes and the clinical phenotype of immunodeficiency in patients with impaired Ca2+ influx and CRAC channel function.

Methods

DNA sequence analysis for mutations in the genes ORAI1, ORAI2, ORAI3, and stromal interaction molecule (STIM) 1 and 2, as well as mRNA and protein expression analysis of ORAI1 in immunodeficient patients. Immunohistochemical analysis of ORAI1 tissue distribution in healthy human donors.

Results

We identified mutations in ORAI1 in patients from 2 unrelated families. One patient is homozygous for a frameshift nonsense mutation in ORAI1 (ORAI1-A88SfsX25), and a second patient is compound heterozygous for 2 missense mutations in ORAI1 (ORAI1-A103E/L194P). All 3 mutations abolish ORAI1 expression and impair Ca2+ influx and CRAC channel function. The clinical syndrome associated with ORAI1 deficiency is characterized by immunodeficiency with a defect in the function but not in the development of lymphocytes, congenital myopathy, and anhydrotic ectodermal dysplasia with a defect in dental enamel calcification. In contrast with the limited clinical phenotype, we found ORAI1 protein expression in a wide variety of cell types and organs.

Conclusion

Ca2+ influx through ORAI1 is crucial for lymphocyte function in vivo. Despite almost ubiquitous ORAI1 expression, the channel has a nonredundant role in only a few cell types judging from the limited clinical phenotype in ORAI1-deficient patients.

Key words: ORAI1, STIM1, CRAC, calcium channel, Ca2+, store-operated Ca2+ entry, T cells, immunodeficiency, signal transduction, congenital myopathy, anhydrotic ectodermal dysplasia, dental enamel, amelogenesis imperfecta

Abbreviations used: CRAC, Ca2+ release activated Ca2+, EDA, Ectodermal dysplasia with anhydrosis, HSCT, Hematopoietic stem cell transplantation, NK, Natural killer, SCID, Severe combined immunodeficiency, SNP, Single nucleotide polymorphism, SOCE, Store-operated Ca2+ entry, STIM, Stromal interaction molecule

 

 Supported by National Institutes of Health grants (S.F., A.R.), a March of Dimes Foundation grant (S.F.), and an INSERM grant (A.F.).

 Disclosure of potential conflict of interest: T. Kawasaki receives research support through the Uehara Postdoctoral Fellowship. J. Kirschner has received research support from the Muscular Dystrophy Network and the TREAT-NMD Network. A. Rao is a founder and advisor of CalciMedica and has received research support from the National Institutes of Health, JDRF, and GlaxoSmithKline. A. Fischer is a contractor for INSERM, the French National Research Agency, and the European Community. S. Feske is a founder and advisor of CalciMedica and has received research support from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, the March of Dimes Foundation, and the Charles Hood Foundation. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01533-4

doi:10.1016/j.jaci.2009.10.007

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1311-1318.e7, December 2009